Head-to-head · WeighScore
Blue Haven RX vs FMmeds
The verdict
FMmeds takes it — 63.2/100 to 50.8/100.
FMmeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FMmeds is a Manhattan Beach-based DTC telehealth platform selling compounded semaglutide and tirzepatide co-formulated with vitamin B12, with no membership fee and a free initial visit billed only on approval.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Blue Haven RX | FMmeds |
|---|---|---|
| WeighScore | 50.8/100 | 63.2/100 |
| Grade | C | C |
| Scorecard rank | #489 | #257 |
| Semaglutide | Not disclosed | $225/mo (all doses, compounded) |
| Tirzepatide | Not disclosed | $265/mo (all doses, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #489 · C
Strengths
- Flat all-inclusive pricing — consult, prescription, medication and free shipping
- Not charged until a US-licensed physician approves your prescription
- Named operating entity disclosed (Eternum Health LLC)
- Both compounded semaglutide and tirzepatide listed as in-stock
Where it loses points
- Mixed third-party reviews — Trustpilot complaints on customer service and dosing
- Doesn't publish the states it serves or specific pharmacy partners
- No clearly verifiable accreditation badge (e.g. LegitScript) on the site
- Compounded semaglutide and tirzepatide only — no brand-name or oral options
Graded #257 · C
Strengths
- All 50 states plus DC covered, stated in the Terms
- Operating LLC and full Manhattan Beach, CA address disclosed
- Named 503A pharmacy partner (Manifest Pharmacy, Greer SC)
- Aggressive 12-month pricing — semaglutide $95/mo and tirzepatide $145/mo, at the low end of the market
- Flat pricing across all dose strengths — no dose-escalation surcharge
Where it loses points
- Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
- Publishes the FDA compounded-medication disclaimer (medication is not FDA-approved)
- Clinical network not separately named
- LegitScript Certified, but the specific ID isn't shown
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.